Chemotherapy of Neoplastic Disease
Author:
- David A. KarnofskyDKDavid A. Karnofsky
- 12 August 1948
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 239 (7) , 260-270
Abstract
The cancer chemotherapist, in the absence of a fundamental philosophy or a satisfactory approach to his problem, is an eclectic, borrowing ideas and discoveries from the more advanced or at least the more fruitful scientific disciplines. The range of his interests and the nature of his approach are shown in the number of chemicals and groups of substances under study. These agents are, for the most part, chiefly of interest in a historical and immediate sense for many, if not all, will ultimately be discarded. Until a fundamental discovery appears, each year will see new agents greeted with enthusiasm, and . . .Keywords
This publication has 80 references indexed in Scilit:
- THE TOXICITY AND PHARMACOLOGICAL ACTION OF THE NITROGEN MUSTARDS AND CERTAIN RELATED COMPOUNDSThe Journal of Pharmacology and Experimental Therapeutics, 1947
- THE REGRESSION OF LYMPHOSARCOMA IMPLANTS IN PYRIDOXINE-DEFICIENT MICEJournal of Biological Chemistry, 1947
- CHEMOTHERAPY OF MULTIPLE MYELOMA; THE USE OF ANTIMONYBlood, 1947
- Clinical observations in patients treated with antireticular cytotoxic serum. Preliminary reportThe American Journal of Medicine, 1947
- SYNTHETIC FOLIC ACIDJAMA, 1947
- The effects of nitrogen mustard on embryonic amphibian development. Part I. Ectodermal effectsJournal of Experimental Zoology, 1947
- STILBAMIDINE AND PENTAMIDINE IN MULTIPLE MYELOMAJAMA, 1947
- LEUKÆMIA TREATED WITH URETHANE COMPARED WITH DEEP X-RAY THERAPYThe Lancet, 1946
- COLCHICINE IN ACUTE MYELOGENOUS LEUKEMIAJAMA, 1945
- THE ADMINISTRATION OF EGG WHITE AND AVIDIN CONCENTRATES TO PATIENTS WITH CANCERJAMA, 1943